10 Jahre Verkehrsprojekte Deutsche Einheit - eine kritische Würdigung = Dix ans de projets sur les transports de l'Allemagne unifiée, une évaluation critiqueKOLB, H.-J.Geographie und Schule. 2000, Vol 22, Num 127, pp 10-17Article

Insulin degrading enzyme activity and insulin binding of erythrocytes in normal subjects and type 2 (non-insulin-dependent) diabetic patientsSANDL, E; KOLB, H. J.Diabetologia (Berlin). 1984, Vol 27, Num 1, pp 17-22, issn 0012-186XArticle

Chronic myeloid leukemia associated hypereosinophilic syndrome with a clonal t(4;7)(q11;q32)DUELL, T; MITTERMÜLLER, J; SCHMETZER, H. M et al.Cancer genetics and cytogenetics. 1997, Vol 94, Num 2, pp 91-94, issn 0165-4608Article

Comparative analysis of the impact of risk profile and of drug therapy on survival in CML using Sokal's index and a new scoreHEHLMANN, R; ANSARI, H; HOCHHAUS, A et al.British journal of haematology. 1997, Vol 97, Num 1, pp 76-85, issn 0007-1048Article

Expression of IGFBP-2, -3, and -4 mRNA during differentiation of Caco-2 colon epithelial cellsHOEFLICH, A; YANG, Y; HUBER, S et al.American journal of physiology. Endocrinology and metabolism. 1996, Vol 34, Num 5, pp E922-E931, issn 0193-1849Article

Identification and characterization of a mouse monoclonal antibody (M10) directed against canine (dog) CD8⁺ lymphocytesVOSS, C; KREMMER, E; HOFFMANN-FEZER, G et al.Veterinary immunology and immunopathology. 1993, Vol 38, Num 3-4, pp 311-325, issn 0165-2427Article

Reversal of P-glycoprotein related resistance by idarubicinNUESSLER, V; GIESELER, F; PELKA-FLEISCHER, R et al.Bone marrow transplantation. Supplement (Basingstoke). 1993, Vol 12, Num 4, pp S162-S163, issn 0951-3078Conference Paper

Role of tumor necrosis factor alpha in acute graft-versus-host disease and complications following allogeneic bone marrow transplantationHOLLER, E; KOLB, H. J; HINTERMEIER-KNABE, R et al.Transplantation proceedings. 1993, Vol 25, Num 1, pp 1234-1236, issn 0041-1345, 2Conference Paper

Allogenic bone marrow transplantation for leukemia in europe : regional differences. Report from the leukemia working party of the European group for bone marrow transplantationGRATWOHL, A; HERMANS, J; ZWAAN, F. E et al.Bone marrow transplantation (Basingstoke). 1990, Vol 5, Num 3, pp 159-165, issn 0268-3369, 7 p.Article

Donor leukocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patientsKOLB, H. J; MITTERMUÊLLER, J; CLEMM, C et al.Blood. 1990, Vol 76, Num 12, pp 2462-2465, issn 0006-4971, 4 p.Article

Opportunistische Virusinfektionen bei abwchgeschwächten Patienten = Infections virales opportunistes chez les sujets immunodéprimés = Opportunistic viral infectious in immunocompromised patientsKOLB, H. J; EBERLE, J; WILMANNS, W et al.AIDS - Forschung. 1988, Vol 3, Num 1, pp 24-28, issn 0179-3098Article

A multiprocessor system for simulating data transmission systems (MUPSI)BOLCH, G; HOFMANN, F; HOPPE, B et al.Microprocessing and microprogramming. 1983, Vol 12, Num 5, pp 267-277, issn 0165-6074Article

Nonmyeloablative stem cell transplantation in adults with high-risk ALL may be effective in early but not in advanced diseaseARNOLD, R; MASSENKEIL, G; KOLB, H. J et al.Leukemia. 2002, Vol 16, Num 12, pp 2423-2428, issn 0887-6924, 6 p.Article

Final height of patients who underwent bone marrow transplantation for hematological disorders during childhood : A study by the working party for late effects-EBMTCOHEN, A; ROVELLI, A; MERLO, F et al.Blood. 1999, Vol 93, Num 12, pp 4109-4115, issn 0006-4971Article

Donor search or autografting in patients with acute leukaemia who lack an HLA-identical sibling ? A matched-pair analysisRINGDEN, O; LABOPIN, M; HAROUSSEAU, J. L et al.Bone marrow transplantation (Basingstoke). 1997, Vol 19, Num 10, pp 963-968, issn 0268-3369Article

Randomized studies with interferon in chronic myelogenous leukemia (CML) and comparative molecular aspectsHEHLMANN, R; WILLER, A; TOBLER, A et al.Leukemia. 1997, Vol 11, pp 506-511, issn 0887-6924, SUP3Conference Paper

Malignant diseases after allogeneic bone marrow transplantation : the case for assessment of risk factorsSOCIE, H; KOLB, H. J; LJUNGMAN, P et al.British journal of haematology. 1992, Vol 80, Num 4, pp 427-430, issn 0007-1048Article

No advantage for patients who receive splenic irradiation before bone marrow transplantation for chronic myeloid leukaemia : results of a prospective randomized studyGRATWOHL, A; HERMANS, J; IRIONDO, A et al.Bone marrow transplantation (Basingstoke). 1992, Vol 10, Num 2, pp 147-152, issn 0268-3369Article

Randomized study on the treatment of chronic myeloid leukemia (CML) in chronic phase with busulfan versus hydroxyurea versus interferon-alphaHEHLMANN, R; ANGER, B; WALTHER, F et al.Blut. 1988, Vol 56, Num 2, pp 87-91, issn 0006-5242Article

Joint report of the third international workshop on canine immunogenetics. I: Analysis of homozygous typing cellsDEEG, H. J; RAFF, R. F; SCHOCH, G et al.Transplantation. 1986, Vol 41, Num 1, pp 111-117, issn 0041-1337Article

Quantitative Bestimmung von Immunglobulinen durch photometrische Trübungsmessung = Dosage des immunoglobulines par mesures photométriques de la turbidité = Quantitative determination of immunoglobulins by turbidity measurementsKELLNER, B; HAUSLER, H; KOLB, H. J et al.Labor - Medizin (GIT-Verlag Giebeler). 1985, Vol 8, Num 3, pp 151-155, issn 0170-205XArticle

Large vessel vasculitis: manifestation of graft-versus-host disease?SOSTAK, P; SAAM, T; HACKER, M et al.Journal of neurology. 2009, Vol 256, Num 11, pp 1947-1949, issn 0340-5354, 3 p.Article

Reduced-intensity conditioning using TBI (8 Gy), fludarabine, cyclophosphamide and ATG in elderly CML patients provides excellent results especially when performed in the early course of the diseaseWEISSER, M; SCHLEUNING, M; LEDDEROSE, G et al.Bone marrow transplantation (Basingstoke). 2004, Vol 34, Num 12, pp 1083-1088, issn 0268-3369, 6 p.Article

Platelet flow cytometric findings in patients undergoing conditioning therapy for allogeneic hematopoietic stem cell transplantationPIHUSCH, R; HÖHNBERG, B; SALAT, C et al.Annals of hematology (Print). 2002, Vol 81, Num 8, pp 454-461, issn 0939-5555Article

Overexpression of insulin-like growth factor-binding protein-2 results in increased tumorigenic potential in Y-1 adrenocortical tumor cellsHOEFLICH, A; FETTSCHER, O; LAHM, H et al.Cancer research (Baltimore). 2000, Vol 60, Num 4, pp 834-838, issn 0008-5472Article